Jinjing Xia
No. 241 West Huaihai Road
Huaihai, 200030, China
Huaihai, 200030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
CHD4 is a copper sensor linking chromatin remodeling to cuproptosis.
Journal: Free radical biology & medicine
Published: January 25, 2026
Artificial Intelligence with Robotics for Metabolic Rehabilitation and Enhanced Patient Recovery in Critical Care.
Journal: Research (Washington, D.C.)
Published: December 07, 2025
miR-941 in extracellular vesicles confers anlotinib resistance via Keap1/Nrf2 axis and represents a therapeutic target in non-small cell lung cancer.
Journal: Clinical and translational medicine
Published: November 19, 2025
Osimertinib for EGFR-Mutant NSCLC Patients With Acquired T790M and EGFR Amplification After First-Generation EGFR-TKI Resistance.
Journal: Cancer science
Published: June 07, 2024
IMpower210: A phase III study of second-line atezolizumab vs. docetaxel in East Asian patients with non-small cell lung cancer.
Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
Published: December 21, 2023
Multi-target angiogenesis inhibitor combined with PD-1 inhibitors may benefit advanced non-small cell lung cancer patients in late line after failure of EGFR-TKI therapy.
Journal: International journal of cancer
Published: February 07, 2023
Loss of BLK expression as a potential predictor of poor prognosis and immune checkpoint blockade response in NSCLC and contribute to tumor progression.
Journal: Translational oncology
Published: January 06, 2023
YAP 5-methylcytosine modification increases its mRNA stability and promotes the transcription of exosome secretion-related genes in lung adenocarcinoma.
Journal: Cancer gene therapy
Published: June 11, 2022
Results from the IMpower132 China cohort: Atezolizumab plus platinum-based chemotherapy in advanced non-small cell lung cancer.
Journal: Cancer medicine
Published: June 10, 2022
ISGylation of EMD promotes its interaction with PDHA to inhibit aerobic oxidation in lung adenocarcinoma.
Journal: Journal of cellular and molecular medicine
Published: May 06, 2022
Treatment strategy, overall survival and associated risk factors among patients with unresectable stage IIIB/IV non-small cell lung cancer in China (2015-2017): A multicentre prospective study.
Journal: The Lancet regional health. Western Pacific
Published: April 25, 2022
The essential roles of m6A RNA modification to stimulate ENO1-dependent glycolysis and tumorigenesis in lung adenocarcinoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 30, 2021
Last Updated: 09/26/2026